← Leaderboards
Santhi Swaroop Vege
Mayo Clinic Rochester
$3,736,625
Attributed
$4,564,834
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $781.7K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,564,834 · 3
By mechanism
U01$3,716,260 · 1
R21$848,574 · 2
Top collaborators
- Gloria M. Petersen6 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Yi Lin$6,996,175
- Paul Limburg$5,310,518
- Evanthia Galanis$13,573,895
- Mark D Topazian$1,483,187
- Sean S Park$1,787,171
Others in their field
Top investigators on “Chronic Pancreatitis”
- Anirban Maitra · Johns Hopkins University$27,518,206
- Miklos Sahin-Toth · University Of California Los Angeles$14,439,858
- Melena D. Bellin · University Of Minnesota$14,012,103
- Michael A Hollingsworth · University Of Nebraska Medical Center$13,279,423
- David A Stoltz · University Of Iowa$11,769,118
- Vincent Falanga · Roger Williams Hospital$11,741,253
Research focus
Chronic PancreatitisPancreatitisPancreasDiagnosisClinical ResearchDiabetes MellitusParticipantLeadClinicSalivaryEnrollmentExocrine PancreasIslets Of LangerhansNon-Insulin-Dependent Diabetes MellitusDesignResearch InfrastructureBiological MarkersMalignant Neoplasm Of PancreasMalignant NeoplasmsAncillary StudyPancreatic DiseasesAcute PancreatitisCohortLeadership
Grant awards (15)
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$512,400
U01 · FY2025 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$457,920
U01 · FY2024 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$477,000
U01 · FY2023 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer (Admin Supplement)$135,521
U01 · FY2023 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$477,000
U01 · FY2022 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$85,420
U01 · FY2022 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$477,000
U01 · FY2021 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$93,810
U01 · FY2021 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$477,000
U01 · FY2020 · DK · contact PI
Phase 1/2 Trial of Indomethacin in Chronic Pancreatitis (The PAIR Trial)$184,724
R21 · FY2020 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$120,000
U01 · FY2020 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$403,189
U01 · FY2019 · DK · contact PI
Phase 1/2 Trial of Indomethacin in Chronic Pancreatitis (The PAIR Trial)$226,600
R21 · FY2019 · DK · contact PI
Oral Pentoxifylline vs. Placebo in Acute Pancreatitis: ... (short title)$198,750
R21 · FY2016 · DK · contact PI
Oral Pentoxifylline vs. Placebo in Acute Pancreatitis: ... (short title)$238,500
R21 · FY2015 · DK · contact PI